RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Revenue

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.5B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Sep 30, 202551,677+12.01%
Sep 30, 202446,138+12.84%
Sep 30, 202340,889+15.42%
Sep 30, 202235,426+4.22%
Sep 30, 202133,990+0.58%
Sep 30, 202033,793-6.85%
Sep 30, 201936,279-4.30%
Sep 30, 201837,909+7.13%
Sep 30, 201735,387+3.38%
Sep 30, 201634,229+8.05%
Sep 30, 201531,680+8.44%
Sep 30, 201429,215+16.05%
Sep 30, 201325,174+16.98%
Sep 30, 201221,520-0.48%
Sep 30, 201121,623

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)